PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19767525-0	2009	Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass.	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	50-64	
19767525-2	2009	Pyruvate reportedly suppresses degradation of the alpha-subunit of hypoxia-inducible factor-1 (HIF-1), an activator of the gene encoding the cardioprotective cytokine erythropoietin (EPO).	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	167-181	
19767525-2	2009	Pyruvate reportedly suppresses degradation of the alpha-subunit of hypoxia-inducible factor-1 (HIF-1), an activator of the gene encoding the cardioprotective cytokine erythropoietin (EPO).	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	183-186	
19767525-8	2009	Pyruvate-fortified cardioplegia stabilized arterial pressure post-CPB, induced myocardial EPO mRNA expression, and increased HIF-1alpha, EPO, and EPO-R protein contents by 60, 58, and 123%, respectively, vs. control cardioplegia (P < 0.05).	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	90-93	
19767525-8	2009	Pyruvate-fortified cardioplegia stabilized arterial pressure post-CPB, induced myocardial EPO mRNA expression, and increased HIF-1alpha, EPO, and EPO-R protein contents by 60, 58, and 123%, respectively, vs. control cardioplegia (P < 0.05).	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	137-140	
19767525-11	2009	Pyruvate-fortified cardioplegia induced myocardial EPO expression and mobilized the EPO-ERK-eNOS mechanism.	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	51-54	
19767525-11	2009	Pyruvate-fortified cardioplegia induced myocardial EPO expression and mobilized the EPO-ERK-eNOS mechanism.	Pyruvic Acid	0-8	erythropoietin	Sus scrofa	84-87	
19767525-12	2009	By stabilizing HIF-1alpha, pyruvate-fortified cardioplegia may evoke sustained activation of EPO"s cardioprotective signaling cascade in myocardium.	Pyruvic Acid	27-35	erythropoietin	Sus scrofa	93-96